Leadership must keep pace to evolve and stay competitive.
BILS.ai brings together global bio innovation leadership across biologics, cell and gene therapy and cultivated protein leaders to clear biomanufacturing bottlenecks with AI, agile capacity and sustainable resilient operations.
01 · BILS.ai
Bio Innovation Leaders Dialogue London 2026
The four pillars of BILS.ai
AI‑enabled bioprocessing
Why it matters: It turns AI from experimentation into a daily control lever for yield, quality and release, so decisions are driven by live process data, not by the last deviation report.
Agile capacity and networks
Why it matters: It keeps capacity from becoming a stranded asset, allowing production to flex with demand and geopolitics instead of locking risk into fixed plants.
Workforce and human systems
Why it matters: It ensures automation and AI amplify human expertise rather than erode it, so factories stay resilient even as technology and portfolios change.
Why it matters:
Sustainable resilient operations
Why it matters: It aligns cost, compliance and climate by cutting resource intensity and strengthening supply continuity, which is now a board‑level expectation, not a side benefit.
02 · THE GAP
Curated for senior biomanufacturing leaders
Why it Matters.
In 2026 AI, automation and digital bioprocessing are moving from pilots into the heart of biomanufacturing.
At the same time companies are committing record capital to new facilities and regional networks while facing tight margins, skills gaps and rising sustainability expectations.
The question is no longer whether these shifts are coming but how to deploy them without breaking cost, compliance or supply.
Cell Biology at Scale.
Three Industries.
One Question.
How Do We Turn Cells into Scalable Solutions?
03 · WHO IT'S CURATED FOR
Leaders on the path to intelligent biomanufacturing - AI‑powered bioprocessing, agile modular capacity, human‑centred Industry 5.0 systems and sustainable, resilient operations for 2026 and beyond.
MANUFACTURING & OPERATIONS
BILS.ai is an invite‑only deployment room for biomanufacturing, built for senior leaders across biologics, CGT and cultivated protein who are turning AI, new capacity and sustainability goals into working plants and networks in 2026.
VP Manufacturing · COO · Site Director · Head of Operations
Quality & Regulatory
VP Quality · Head of QA · Chief Quality Officer · RA Lead
It is a curated, invite‑only meeting in London for senior decision makers from biologics, cell and gene therapy and cultivated protein who sign off the next wave of capacity, technology and partnership commitments.
MSAT & PROCESS DEVELOPMENT
Head of MSAT · VP Tech Ops · Process Development Lead
Over two days the focus stays on four pillars – AI‑enabled bioprocessing, agile capacity and networks, workforce and human systems and sustainable resilient operations – because that is where 2026 decisions are actually made.
DIGITAL, DATA & R&D
VPs Innovation · VP Digital · Head of Data Science Digital Transformation Lead · Heads of R&D · Automation · Infrastructure
For technology providers and CDMOs BILS.ai is where current bioprocess and biomanufacturing trends turn into multi‑year deployment roadmaps.
For operators it is a chance to stress‑test strategies with peers who are facing the same pressures on performance, resilience and sustainability and need answers they can put into practice in their own plants.
Advisory Circle.
Advisory & Past Speakers
For the few: leaders who sign for cost, compliance and supply when AI touches production
The AIO feature is for leaders willing to sign their name under AI-enabled decisions.
www.aiocircle.com
 |
|---|
Step into the circle. Subscribe.
Stay updated. Receive the agenda. Partner with us.
